Hainan Poly Pharmaceuticals

Hainan Poly Pharmaceuticals is a leading Chinese specialty pharmaceutical company focused on the research, development, manufacturing, and global commercialization of high-end generic drugs and contrast agents. Founded in 1992, the company has established a robust international presence, securing numerous product approvals from the US FDA, EU EMA, and WHO. Its core portfolio specializes in complex injectable formulations across therapeutic areas such as anti-infectives, cardiovascular health, and diagnostic imaging. In addition to its proprietary product line, Hainan Poly provides comprehensive CDMO services, leveraging its GMP-compliant manufacturing facilities in China. The company is publicly listed on the Shenzhen Stock Exchange and is recognized for its commitment to high-quality production standards and international market expansion.